126 related articles for article (PubMed ID: 2873280)
1. Psoriasis and alpha-interferon.
Quesada JR; Gutterman JU
Lancet; 1986 Jun; 1(8496):1466-8. PubMed ID: 2873280
[TBL] [Abstract][Full Text] [Related]
2. Psoriasis induced by interferon-alpha.
Funk J; Langeland T; Schrumpf E; Hanssen LE
Br J Dermatol; 1991 Nov; 125(5):463-5. PubMed ID: 1751354
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of alpha interferon on renal cell carcinoma. Summary of three collaborative trials.
Umeda T; Niijima T
Cancer; 1986 Sep; 58(6):1231-5. PubMed ID: 3742449
[TBL] [Abstract][Full Text] [Related]
4. Improvement of psoriasis and cutaneous side-effects during tyrosine kinase inhibitor therapy for renal metastatic adenocarcinoma. A role for epidermal growth factor receptor (EGFR) inhibitors in psoriasis?
Wierzbicka E; Tourani JM; Guillet G
Br J Dermatol; 2006 Jul; 155(1):213-4. PubMed ID: 16792781
[No Abstract] [Full Text] [Related]
5. Antitumor activity of recombinant-derived interferon alpha in metastatic renal cell carcinoma.
Quesada JR; Rios A; Swanson D; Trown P; Gutterman JU
J Clin Oncol; 1985 Nov; 3(11):1522-8. PubMed ID: 4056843
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of metastatic renal cell carcinoma with human lymphoblastoid interferon].
Ryu S; Fukuoka M; Tamai S; Takifuji N; Sakai N; Matsui K; Negoro S; Takada M; Kusunoki Y
Nihon Gan Chiryo Gakkai Shi; 1987 Jun; 22(5):996-1002. PubMed ID: 3694004
[No Abstract] [Full Text] [Related]
7. A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial.
Kirkwood JM; Harris JE; Vera R; Sandler S; Fischer DS; Khandekar J; Ernstoff MS; Gordon L; Lutes R; Bonomi P
Cancer Res; 1985 Feb; 45(2):863-71. PubMed ID: 3881175
[TBL] [Abstract][Full Text] [Related]
8. Phase II results with recombinant interferons: renal cell carcinoma and malignant melanoma.
Kuzmits R; Kokoschka EM; Micksche M; Ludwig H; Flener R
Oncology; 1985; 42 Suppl 1():26-32. PubMed ID: 4080298
[TBL] [Abstract][Full Text] [Related]
9. Phase II study of interferon alpha in metastatic renal-cell carcinoma: a progress report.
Quesada JR; Swanson DA; Gutterman JU
J Clin Oncol; 1985 Aug; 3(8):1086-92. PubMed ID: 4020410
[TBL] [Abstract][Full Text] [Related]
10. Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma.
Quesada JR; Evans L; Saks SR; Gutterman JU
J Biol Response Mod; 1988 Jun; 7(3):234-9. PubMed ID: 3134511
[TBL] [Abstract][Full Text] [Related]
11. A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.
Ernstoff MS; Nair S; Bahnson RR; Miketic LM; Banner B; Gooding W; Day R; Whiteside T; Hakala T; Kirkwood JM
J Clin Oncol; 1990 Oct; 8(10):1637-49. PubMed ID: 2120392
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of metastatic renal adenocarcinomas with combined recombinant alpha-2a interferon and vinblastine].
Bergerat JP; Dufour P; Soyer Y; Bollack C; Jacqmin D; Prevot G; Juraschek F; Bailly G; de Garis S; Lang JM
Presse Med; 1987 Nov; 16(39):1953-6. PubMed ID: 2962158
[TBL] [Abstract][Full Text] [Related]
13. The use of interferon alpha-C in patients with metastatic renal cell carcinoma arising in a congenital solitary kidney.
Merimsky O; Merimsky E; Chaitchik S
J Surg Oncol; 1990 Dec; 45(4):279-81. PubMed ID: 2250479
[TBL] [Abstract][Full Text] [Related]
14. [Biological effect of recombined leukocyte alpha-2-interferon in metastasizing colorectal cancers].
Niederle N; Kurschel E; Schmidt CG
Dtsch Med Wochenschr; 1984 May; 109(20):779-82. PubMed ID: 6723531
[TBL] [Abstract][Full Text] [Related]
15. Treatment of renal cell carcinoma with daily low-dose alpha-interferon.
Marshall ME; Simpson W; Butler K; Fried A; Fer M
J Biol Response Mod; 1989 Oct; 8(5):453-61. PubMed ID: 2795090
[TBL] [Abstract][Full Text] [Related]
16. [Medical treatment of metastatic cancer of the kidney with a combination of vinblastine and recombinant interferon alpha IIa. Result of a phase I-II trial].
Jacqmin D; Bergerat JP; Dufour P; Bollack C; Prévot G; Jurascheck F; Bailly G; Degaris S; Oberling F
J Urol (Paris); 1987; 93(8):463-6. PubMed ID: 3440838
[TBL] [Abstract][Full Text] [Related]
17. [Effect of recombinant alpha-interferon on advanced renal cell carcinoma].
Isaka S; Okano T; Akimoto S; Shimazaki J; Murakami S; Igarashi T; Kitamura Y; Yamaguchi K; Kataumi S; Ohtsuka K
Hinyokika Kiyo; 1985 Dec; 31(12):2209-14. PubMed ID: 3832921
[TBL] [Abstract][Full Text] [Related]
18. [The treatment of renal cell carcinoma with recombinant human leukocyte interferon].
Kawamura J; Yamauchi T; Hashimura T; Yoshida O; Kohnami T; Tomoyoshi T; Ogura K; Fukuyama T; Nakagawa K
Hinyokika Kiyo; 1985 Mar; 31(3):377-86. PubMed ID: 4025077
[TBL] [Abstract][Full Text] [Related]
19. [Exacerbation of psoriasis during alpha-interferon therapy].
Hartmann F; von Wussow P; Deicher H
Dtsch Med Wochenschr; 1989 Jan; 114(3):96-8. PubMed ID: 2912680
[TBL] [Abstract][Full Text] [Related]
20. Renal cell carcinoma: antitumor effects of leukocyte interferon.
Quesada JR; Swanson DA; Trindade A; Gutterman JU
Cancer Res; 1983 Feb; 43(2):940-7. PubMed ID: 6336662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
